Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 US Academic CentersTimothy Voorhees,Eric McLaughlin,Pallawi Torka,Jorge A. Florindez,Tamara K. Moyo,Heather Reves,Nuttavut Sumransub,Saarang Deshpande,Ashley Rose,Cassandra Duarte,Muhammad Salman Faisal, Showkat Hamid,Suki Subbiah,Sabarish R. Ayyappan,Lauren Kelly Shea,Matthew J. Cortese,Krish Patel,Ajay Major,Hayder Saeed,Jakub Svoboda,Sanjal H. Desai,Praveen Ramakrishnan Geethakumari,Natalie S. Grover,Narendranath EpperlaBLOOD（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
